Dr. Singh believes in looking at the complete picture of a patient including detailing various aspects of personal past history and linking this with family history and current clinical findings to direct a specified care plan.
Dr. Krishna Singh is triple board certified in Obstetrics and Gynecology, Maternal Fetal Medicine, and Medical Genetics and Genomics. She has expertise in diagnostic evaluation and advanced molecular testing of adults and fetuses with rare genetic conditions. Dr. Singh guides in reproductive planning and care of pregnancies among couples with personal or family history of heritable disease, as well as interpretation of fetal ultrasound and evaluation of prior fetal or neonatal loss.
Dr. Singh's research interests include identifying fetal presentations of rare genetic disorders and use of prenatal screening tests to predict various obstetrical outcomes.
Fetal Care and Treatment Center
Maternal Fetal Medicine
M.D., St. George’s University School of Medicine, Grenada, West Indies 2004
Obstetrics and Gynecology, Albany Medical Center, Albany NY 2004-2005
Obstetrics and Gynecology, University of Tennessee Health Science Center, Memphis TN 2005-2008
Maternal Fetal Medicine, Cedars-Sinai Medical Center, Los Angeles CA 2010-2013
Clinical Genetics, Intercampus Medical Genetics Program at the UCLA, Los Angeles CA 2008-2010
Cedars-Sinai Fellows Award for Excellence in Research, 2013
Singh K, Williams J 3rd, Brown J, Wang ET, Lee B, Gonzalez TL, Cui J, Goodarzi MO, Pisarska MD. Up-regulation of microRNA-202-3p in first trimester placenta of pregnancies destined to develop severe preeclampsia, a pilot study. Pregnancy Hypertens. 2017 Oct;10:7-9. doi:10.1016/j.preghy.2017.04.002. Epub 2017 May 8. PMID:29153693.
Singh K, Moore S, Sandoval M, Balzer B, Frishberg D, Lewin S, Schreck R, Raffel L. Congenital malignant melanoma: a case report with cytogenetic studies. Am J Dermatopathol. 2013 Dec;35(8):e135-8. doi:10.1097/DAD.0b013e318284a679. PMID:23907318.
Singh K, Lester J, Karlan B, Bresee C, Geva T, Gordon O. Impact of family history on choosing risk-reducing surgery among BRCA mutation carriers. Am J Obstet Gynecol. 2013 Apr;208(4):329.e1-6. doi:10.1016/j.ajog.2013.01.026. Epub 2013 Jan 17. PMID:23333547.
ElNaggar AC, Patil AS, Singh K, Reed ME. Neuroendocrine carcinoma of the vagina in pregnancy. Obstet Gynecol. 2012 Feb;119(2 Pt 2):445-447. doi:10.1097/AOG.0b013e318236ffcd. PMID:22270433.
Rajendra K, Bringman JJ, Ward J, Phillips OP. Who should be tested for fragile X carriership? A review of 1 center's pedigrees. Am J Obstet Gynecol. 2008 May;198(5):e51-3. doi:10.1016/j.ajog.2007.12.023. Epub 2008 Mar 20. PMID:18358452.